gene

MLCK

Entity Detail — Knowledge Graph Node

Understanding Entity Pages

This page aggregates everything SciDEX knows about MLCK: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.

294Connections
0Hypotheses
1Analyses
50Outgoing
50Incoming

Summary

MLCK is a gene implicated in neurodegeneration research. Key relationships include: activates, interacts with, inhibits. Associated with Inflammation, Ms, Ulcerative Colitis. Connected to 27 entities in the SciDEX knowledge graph.

View on Wiki →

🧬 Gene Info
Gene SymbolMLCK
Full NameMyosin light chain kinase
Chromosome3p21.31
Protein TypeKinase
Target ClassKinase
FunctionMLCK inhibitors block the phosphorylation of myosin light chains, thereby reducing cytoskeletal contraction and stabilizing tight junctions at the blood-brain barrier and endothelial surfaces. This...
Mechanism of ActionMLCK inhibitors block the phosphorylation of myosin light chains, thereby reducing cytoskeletal contraction and stabilizing tight junctions at the blood-brain barrier and endothelial surfaces. This mechanism reduces vascular permeability and preserves barrier integrity in conditions characterized by excessive leakage or cytoskeletal dysfunction.
Primary ExpressionBrain (cerebellum), Smooth muscle, Heart
DruggabilityLow (0.40)
Clinical StagePhase II
Molecular Weight220 kDa
Gene TypeProtein coding
PathwaysNf-Κb
UniProt IDQ9Y463
NCBI Gene ID3371
Ensembl IDENSG00000139792
OMIM600922
GeneCardsMLCK
Human Protein AtlasMLCK
Associated DiseasesALS, neurodegeneration, stroke
Known Drugs/CompoundsLifibrate
InteractionsCLDN1, OCLN, ZO1, TNF, PPAR, p-MLC
SciDEX TargetView Target Profile (4 clinical trials)
KG Connections294 knowledge graph edges
DatabasesGeneCardsHPASTRING
🔮 Predicted Structure: MLCK — AlphaFold Q9Y463 Click to expand

AI-predicted structure from AlphaFold | Powered by Mol*

Wiki Pages (21)

Knowledge base pages for this entity

Canonical Page

MLCK Gene

gene · 2963 words

CALM4 — Calmodulin 4

gene · 3697 words

Section 182: Microbiome Metabolomics and SCFA Therapy in CBS/PSP

therapeutic · 3021 words

Microbiome Metabolomics and SCFA Therapy for CBS/PSP

therapeutic · 2671 words

Blarcamesine (ALX-001)

therapeutic · 2127 words

Section 123: Microbiome-Gut-Brain Axis Interventions for CBS/PSP

therapeutic · 1889 words

Pathway Diagram

graph TD
    MLCK["<b>MLCK</b>"]
    MLC2["MLC2"]
    MLCK -->|"phosphorylates"| MLC2
    Ms{"Ms"}
    MLCK -->|"activates"| Ms
    Inflammation{"Inflammation"}
    MLCK -->|"activates"| Inflammation
    TNF["TNF"]
    MLCK -->|"activates"| TNF
    OCLN["OCLN"]
    MLCK -->|"activates"| OCLN
    IL_6["IL-6"]
    MLCK -->|"activates"| IL_6
    CLDN1["CLDN1"]
    MLCK -->|"activates"| CLDN1
    INFLAMMATION["INFLAMMATION"]
    MLCK -->|"activates"| INFLAMMATION
    PPAR["PPAR"]
    MLCK -->|"inhibits"| PPAR
    Macrophage["Macrophage"]
    MLCK -->|"expressed in"| Macrophage
    neurodegeneration{"neurodegeneration"}
    MLCK -->|"associated with"| neurodegeneration
    MLCK -->|"interacts with"| CLDN1
    h_6c83282d["h-6c83282d"]
    h_6c83282d -->|"therapeutic target"| MLCK
    Betulinic_Acid["Betulinic Acid"]
    Betulinic_Acid -->|"downregulates"| MLCK
    OCLN -->|"activates"| MLCK
    TNF -->|"activates"| MLCK
    CLDN1 -->|"activates"| MLCK
    PPAR -->|"inhibits"| MLCK
    INFLAMMATION -->|"activates"| MLCK
    AND["AND"]
    AND -->|"inhibits"| MLCK
    CLDN1 -->|"interacts with"| MLCK
    OCLN -->|"interacts with"| MLCK
    ZO1["ZO1"]
    ZO1 -->|"interacts with"| MLCK
    style MLCK fill:#1a3a4a,stroke:#4fc3f7,stroke-width:3px,color:#e0e0e0

Outgoing (210)

TargetRelationTypeStr
blood-brain barrierexpressed_inbrain_region0.90
blood-brain barrierparticipates_inpathway0.90
strokeinhibitsdisease0.70
NF-kB signalingparticipates_inpathway0.70
macrophagesinhibitscell_type0.70

Incoming (84)

SourceRelationTypeStr
h-6c83282dtargets_genehypothesis0.90
OCLNactivatesgene0.60
TNFactivatesgene0.60
CLDN1activatesgene0.60
PPARinhibitsgene0.60

Targeting Hypotheses (0)

Hypotheses where this entity is a therapeutic target

HypothesisScoreDiseaseAnalysis
No targeting hypotheses

Mentioning Analyses (1)

Scientific analyses that reference this entity

What are the mechanisms by which gut microbiome dysbiosis influences Parkinson's

neurodegeneration | 2026-04-01 | 20 hypotheses Top: 0.617

Related Papers (0)

Scientific publications cited in analyses involving this entity

Title & PMIDAuthorsJournalYearCitations
No papers found